Catalyst Wire Dossier Catalyst Wire Dossier

ZENBEXUS

IBERDOMIDE · BRISTOL MYERS SQUIBB
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZENBEXUS, covering 2026-08-13 to 2026-08-13. Get the full timeline:

Most recent: FDA Approved: ZENBEXUS — Original Application (BRISTOL MYERS SQUIBB)

See pricing